High expression level (above the median value) of activated c-Src within the nucleus of tumour cells was significantly associated with improved overall survival (P=0.047) and decreased recurrence in tamoxifen-treated patients (P=0.02), Figure 3A and B. The gene discussed is SRC; the disease is neoplasm.